Bio Green Med Solution, Inc. (BGMSP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 700K 1.4M 2.1M FY09: 911K FY10: 112K FY11: 699K FY12: 69K FY13: 1.1M FY14: 1.7M FY15: 1.9M FY16: 843K FY17: 0 FY18: 150K FY20: 0 FY21: 0 FY22: 0 FY23: 420K FY24: 43K FY25: 747K FY10 FY12 FY14 FY16 FY18 FY21 FY23 FY25

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

-30M -20M -10M 0 10M 20M 30M FY09: -18.3M FY10: -15.1M FY11: -15.7M FY12: -15.1M FY13: -18M FY14: -22.4M FY15: -16.2M FY16: -14.2M FY17: -9.5M FY18: -9.5M FY19: -9.7M FY20: -10.6M FY21: -22.4M FY22: -27.7M FY23: -25.5M FY24: -12M FY25: -8.4M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY04: -22.7M FY05: -18M FY06: -29.3M FY07: -24.1M FY08: -40.4M FY09: -19.6M FY10: -16M FY11: -15.2M FY12: -13.2M FY13: -10.2M FY14: -19.4M FY15: -14.3M FY16: -11.8M FY17: -7.5M FY18: -7.3M FY19: -7.8M FY20: -8.4M FY21: -18.5M FY22: -21.2M FY23: -22.6M FY24: -11.2M FY25: -3M FY05 FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-24M -16M -8M 0 8M 16M 24M FY09: -14.9M FY10: -16M FY11: -14M FY12: -12M FY13: -18.2M FY14: -18.7M FY15: -14.5M FY16: -10.1M FY17: -7.5M FY18: -6.7M FY19: -9.4M FY20: -7.9M FY21: -18.5M FY22: -20.8M FY23: -16.1M FY24: -8M FY25: -4.8M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-24M -16M -8M 0 8M 16M 24M FY09: -14.9M FY10: -16.1M FY11: -14M FY12: -12.1M FY13: -18.4M FY14: -19M FY15: -14.5M FY16: -10.1M FY17: -7.5M FY18: -6.7M FY19: -9.5M FY20: -8M FY21: -18.6M FY22: -20.8M FY23: -16.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 8M 16M 24M FY09: 22.2M FY10: 5.4M FY11: 7.2M FY12: 8.3M FY13: 15.2M FY20: 3.6M FY21: 8.9M FY22: 11.3M FY23: 3.5M FY24: 22.3K FY25: 2.2M FY09 FY10 FY11 FY12 FY13 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-240.00 -160.00 -80.00 0.00 80.00 160.00 240.00 Q4 '11: -1.14 Q1 '12: -1.44 Q2 '12: -1.81 Q3 '12: -1.59 Q4 '12: -1.69 Q1 '14: -0.60 Q2 '14: -0.92 Q3 '14: -0.82 Q4 '14: -0.90 Q1 '15: -0.84 Q2 '15: -1.81 Q3 '15: -2.54 Q4 '15: -3.49 Q1 '16: -4.34 Q2 '16: -4.16 Q3 '16: -4.07 Q4 '16: -3.52 Q1 '17: -2.86 Q2 '17: -2.35 Q3 '17: -2.40 Q4 '17: -1.95 Q1 '18: -1.69 Q2 '18: -1.35 Q3 '18: -0.62 Q4 '18: -0.63 Q1 '19: -3.28 Q2 '19: -5.25 Q3 '19: -7.34 Q4 '19: -9.93 Q1 '20: -8.64 Q2 '20: -7.09 Q3 '20: -5.29 Q4 '20: -4.14 Q1 '21: -3.16 Q2 '21: -3.14 Q3 '21: -3.21 Q4 '21: -2.11 Q1 '22: -2.03 Q2 '22: -1.93 Q3 '22: -1.81 Q4 '22: -27.25 Q4 '24: -230.70 Q1 '25: -228.43 Q2 '25: -57.23 Q3 '25: -14.74 Q4 '25: -5.88 Q3 '12 Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21 Q3 '22 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.